Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 04, 2015 2:03 AM ET

Biotechnology

Company Overview of Virobay Inc.

Key Executives for Virobay Inc.

NameBoard RelationshipsTitleAge
Robert F. G. Booth Ph.D.22 RelationshipsCo-Founder, Chairman, Chief Executive Officer, President and Secretary60
Heather Preston M.D.53 RelationshipsCo-Founder, Director, Chairperson of Nominating & Corporate Governance Committee and Member of Audit Committee48
James H. Welch No RelationshipsChief Financial & Accounting Officer and Senior Vice President56
Kyle C. Elrod B.A.No RelationshipsSenior Vice President of Project Management and Operations47
David B. Karpf M.D.No RelationshipsChief Medical Officer59
View More Key Executives

Virobay Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert F. G. Booth Ph.D. 22 RelationshipsVirobay Inc.60
Heather Preston M.D. 53 RelationshipsVirobay Inc.48
Thomas John Dietz Ph.D. 48 RelationshipsTranscept Pharmaceuticals, Inc.50
Daniel S. Janney MBA 86 RelationshipsAlta Partners LP48
Jeffrey W. Bird M.D., Ph.D. 99 RelationshipsSutter Hill Ventures53
View All Board Members

Virobay Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Ph.D.Thomas John Dietz48 Relationships3 Executives
Compensation Committee Ph.D.Thomas John Dietz48 Relationships3 Executives
Nominating Committee M.D.Heather Preston53 Relationships3 Executives
Corporate Governance Committee M.D.Heather Preston53 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$355.4K
355.4K
396.2K
Bonus
Not meaningful
Total Short Term Compensation
Not meaningful
Total Value of Options$355.4K
355.4K
33.1M
Compensation as of Fiscal Year 2013
Virobay Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Energizer Holdings Inc. Announce Composition of New Boards of Directors
April 27, 2015 9:00 PM ET
Anders Nyrén to Leave His Assignment as Member of SCA Board of Directors as of April 30, 2015
April 27, 2015 5:58 AM ET
The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Virobay Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.